FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022953341> ?p ?o ?g. }

• W2022953341 endingPage "S94" @default.
• W2022953341 startingPage "S80" @default.
• W2022953341 abstract "Caspase-9 is a critical downstream effector molecule involved in apoptosis, a cell death process thought to be involved in the demise of dopamine (DA) neurons in the substantia nigra (SN) affected by Parkinson's disease (PD). In this study, we determined that a tetracycline-regulated adenovirus harboring a dominant-negative form of caspase-9 (Casp9DN) and the marker gene, enhanced green fluorescent protein (EGFP), under the control of a bidirectional promoter could each be regulated in vitro and in vivo by doxycycline. We next observed that Casp9DN gene delivery significantly protected against TNFalpha and cycloheximide-induced chromatin condensation in HeLa cells and prevented chromatin condensation and the appearance of the early apoptotic marker annexin V in 6-hydroxydopamine (6-OHDA) treated MN9D cells, a dopaminergic cell line. Effects of Casp9DN on DA neurons in vivo were also assessed. DA neurons were retrogradely labeled with fluorogold (FG) and transduced with Casp9DN and EGFP or EGFP alone. A progressive lesion of DA neurons was induced by striatal injection of 6-OHDA 1 week later. At 2 weeks post-lesion, a morphometric analysis of FG+ neurons in the SN revealed that the mean cell diameter of FG labeled neurons in the Casp9DN group was 8% and 21% larger than the EGFP and PBS groups, respectively (P <0.05). However, there was no difference among the treatment groups in the number of neurons remaining in the lesioned SN. These results suggest that while inhibiting apoptosis at the level of caspase-9 is protective in vitro, it is not protective against 6-OHDA-induced cell death in vivo." @default.
• W2022953341 created "2016-06-24" @default.
• W2022953341 creator A5021979312 @default.
• W2022953341 creator A5027781323 @default.
• W2022953341 creator A5056302980 @default.
• W2022953341 creator A5085135836 @default.
• W2022953341 creator A5091428631 @default.
• W2022953341 date "2005-02-01" @default.
• W2022953341 modified "2023-10-09" @default.
• W2022953341 title "A tetracycline-regulated adenovirus encoding dominant-negative caspase-9 is regulated in rat brain and protects against neurotoxin-induced cell death in vitro, but not in vivo" @default.
• W2022953341 cites W1573146315 @default.
• W2022953341 cites W1583371287 @default.
• W2022953341 cites W1832527043 @default.
• W2022953341 cites W1940692702 @default.
• W2022953341 cites W1946523045 @default.
• W2022953341 cites W1965575645 @default.
• W2022953341 cites W1974074671 @default.
• W2022953341 cites W1976749972 @default.
• W2022953341 cites W1978926564 @default.
• W2022953341 cites W1988463041 @default.
• W2022953341 cites W1992637685 @default.
• W2022953341 cites W1993580305 @default.
• W2022953341 cites W1995419071 @default.
• W2022953341 cites W2010275946 @default.
• W2022953341 cites W2011850283 @default.
• W2022953341 cites W2012173926 @default.
• W2022953341 cites W2017268461 @default.
• W2022953341 cites W2017857028 @default.
• W2022953341 cites W2027576252 @default.
• W2022953341 cites W2033721300 @default.
• W2022953341 cites W2036533672 @default.
• W2022953341 cites W2043651078 @default.
• W2022953341 cites W2045309540 @default.
• W2022953341 cites W2046179803 @default.
• W2022953341 cites W2050709677 @default.
• W2022953341 cites W2052853635 @default.
• W2022953341 cites W2054681435 @default.
• W2022953341 cites W2054887138 @default.
• W2022953341 cites W2056365448 @default.
• W2022953341 cites W2056469110 @default.
• W2022953341 cites W2056500423 @default.
• W2022953341 cites W2062679237 @default.
• W2022953341 cites W2062853648 @default.
• W2022953341 cites W2065000444 @default.
• W2022953341 cites W2068608662 @default.
• W2022953341 cites W2074678011 @default.
• W2022953341 cites W2076502151 @default.
• W2022953341 cites W2077764660 @default.
• W2022953341 cites W2078462340 @default.
• W2022953341 cites W2078706567 @default.
• W2022953341 cites W2084344896 @default.
• W2022953341 cites W2087450028 @default.
• W2022953341 cites W2090161008 @default.
• W2022953341 cites W2090429649 @default.
• W2022953341 cites W2094469208 @default.
• W2022953341 cites W2096298540 @default.
• W2022953341 cites W2118566161 @default.
• W2022953341 cites W2119683782 @default.
• W2022953341 cites W2120939161 @default.
• W2022953341 cites W2122376957 @default.
• W2022953341 cites W2132915524 @default.
• W2022953341 cites W2138152051 @default.
• W2022953341 cites W2149610637 @default.
• W2022953341 cites W2150857721 @default.
• W2022953341 cites W2150881749 @default.
• W2022953341 cites W2157999078 @default.
• W2022953341 cites W2165721689 @default.
• W2022953341 cites W4240479615 @default.
• W2022953341 doi "https://doi.org/10.1016/j.expneurol.2004.08.024" @default.
• W2022953341 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15629764" @default.
• W2022953341 hasPublicationYear "2005" @default.
• W2022953341 type Work @default.
• W2022953341 sameAs 2022953341 @default.
• W2022953341 citedByCount "21" @default.
• W2022953341 countsByYear W20229533412012 @default.
• W2022953341 countsByYear W20229533412019 @default.
• W2022953341 countsByYear W20229533412020 @default.
• W2022953341 crossrefType "journal-article" @default.
• W2022953341 hasAuthorship W2022953341A5021979312 @default.
• W2022953341 hasAuthorship W2022953341A5027781323 @default.
• W2022953341 hasAuthorship W2022953341A5056302980 @default.
• W2022953341 hasAuthorship W2022953341A5085135836 @default.
• W2022953341 hasAuthorship W2022953341A5091428631 @default.
• W2022953341 hasConcept C150903083 @default.
• W2022953341 hasConcept C153911025 @default.
• W2022953341 hasConcept C190283241 @default.
• W2022953341 hasConcept C207001950 @default.
• W2022953341 hasConcept C31573885 @default.
• W2022953341 hasConcept C55493867 @default.
• W2022953341 hasConcept C86803240 @default.
• W2022953341 hasConcept C95444343 @default.
• W2022953341 hasConceptScore W2022953341C150903083 @default.
• W2022953341 hasConceptScore W2022953341C153911025 @default.
• W2022953341 hasConceptScore W2022953341C190283241 @default.
• W2022953341 hasConceptScore W2022953341C207001950 @default.
• W2022953341 hasConceptScore W2022953341C31573885 @default.
• W2022953341 hasConceptScore W2022953341C55493867 @default.
• W2022953341 hasConceptScore W2022953341C86803240 @default.

• next